Reviva Pharmaceuticals Holdings, Inc. (RVPH)
0.5324
-0.01
(-1.12%)
USD |
OTCM |
Sep 09, 16:00
Reviva Pharmaceuticals Holdings Enterprise Value : -12.77M for Sept. 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 09, 2026 | -12.77M |
| September 08, 2026 | -12.69M |
| September 04, 2026 | -12.80M |
| September 03, 2026 | -12.67M |
| September 02, 2026 | -12.73M |
| September 01, 2026 | -13.06M |
| August 31, 2026 | -13.45M |
| August 28, 2026 | -12.95M |
| August 27, 2026 | -13.13M |
| August 26, 2026 | -13.13M |
| August 25, 2026 | -13.26M |
| August 24, 2026 | -13.47M |
| August 21, 2026 | -13.41M |
| August 20, 2026 | -13.32M |
| August 19, 2026 | -13.19M |
| August 18, 2026 | -13.72M |
| August 17, 2026 | -13.16M |
| August 14, 2026 | -13.06M |
| August 13, 2026 | -13.13M |
| August 12, 2026 | -13.71M |
| August 11, 2026 | -13.85M |
| August 10, 2026 | -14.11M |
| August 07, 2026 | -14.12M |
| August 06, 2026 | -13.49M |
| August 05, 2026 | -13.85M |
| Date | Value |
|---|---|
| August 04, 2026 | -12.93M |
| August 03, 2026 | -14.50M |
| July 31, 2026 | -14.01M |
| July 30, 2026 | -14.01M |
| July 29, 2026 | -14.37M |
| July 28, 2026 | -14.21M |
| July 27, 2026 | -13.17M |
| July 24, 2026 | -13.55M |
| July 23, 2026 | -13.58M |
| July 22, 2026 | -14.24M |
| July 21, 2026 | -13.98M |
| July 20, 2026 | -12.67M |
| July 17, 2026 | -12.34M |
| July 16, 2026 | -12.52M |
| July 15, 2026 | -12.09M |
| July 14, 2026 | -12.52M |
| July 13, 2026 | -11.97M |
| July 10, 2026 | -11.62M |
| July 09, 2026 | -12.71M |
| July 08, 2026 | -12.80M |
| July 07, 2026 | -11.88M |
| July 06, 2026 | -11.49M |
| July 02, 2026 | -11.09M |
| July 01, 2026 | -11.12M |
| June 30, 2026 | -11.50M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Jaguar Health, Inc. | 11.80M |
| ANI Pharmaceuticals, Inc. | 1.859B |
| Corcept Therapeutics, Inc. | 12.19B |
| Veru, Inc. | 19.18M |
| Johnson & Johnson | 671.47B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.448M |
| Total Expenses (Quarterly) | 2.448M |
| EPS Diluted (Quarterly) | -0.1853 |
| Earnings Yield | -435.2% |
| Normalized Earnings Yield | -435.23 |